25.08.2014
- Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. The...
06.12.2010
- Roche Holding Chief Executive Severin Schwan believes the survivors in the pharmaceuticals sector will be large generic drugmakers, and companies who make innovative new products...
22.09.2010
- Drugmaker Glaxosmithkline sued Swiss rival Roche on Tuesday for infringing a patent when it produces its cancer drug Herceptin, according to court documents filed on Monday. Glaxo...
31.08.2010
- U.S. biotech company Genzyme rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis on Monday, setting the stage for a protracted and potentially hostile...
30.08.2010
- Swiss drugmaker Roche Holding said on Sunday it would not make any decision on job cuts this week, after Swiss newspaper Sonntag reported it could be about to cut thousands of...
25.08.2010
- Swiss drugmaker Roche Holding is entering a deal with U.S.-based Aileron Therapeutics worth up to $1.1 billion, giving it access to a new way of targeting diseases. Aileron, which...
24.08.2010
- Swiss drugmaker Roche Holding is buying U.S. - based Bioimagene for some $100 million, making another bolt-on acquisition to cement its dominant position in tissue-based cancer...
